PTN vs PYPD

Palatin Technologies, Inc. vs PolyPid Ltd. — Valuation Comparison 2026

PTN

Biotechnology
Palatin Technologies, Inc.
Quality
5.7
out of 10
Value Trap
33
LOW
Price
$14.00
Last close
Models
9/13
Active
VS

PYPD

Biotechnology
PolyPid Ltd.
Quality
1.8
out of 10
Value Trap
Price
$4.76
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType PTN Fair ValuePTN Upside PYPD Fair ValuePYPD Upside
Bayesian DCF Intrinsic $5.76 -58.8% $1.26 -73.5%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $27.14 +93.9% $0.30 -93.7%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $11.29 -19.4% $26.22 +450.9%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for PTN vs PYPD — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

PTN vs PYPD — Which Stock Is More Undervalued?

PTN scores higher with a 5.7/10 quality rating vs PYPD's 1.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Palatin Technologies, Inc. (PTN) and PolyPid Ltd. (PYPD) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

PTN currently trades at $14.00 with a QOC of 5.7/10, while PYPD trades at $4.76 with a QOC of 1.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).